Label: information for the user
Diclofenaco Teva 30 mg/g gel
diclofenac sodium
Read this label carefully before starting to use this medication, as it contains important information for you.
Diclofenaco Teva contains diclofenac sodium as the active ingredient. Diclofenac sodium is an anti-inflammatory non-steroidal active ingredient. This medication is used, applied to the skin, for the treatment of a skin condition known as solar or actinic keratosis caused by prolonged exposure to solar radiation.
Do not use Diclofenaco Teva:
Warnings and precautions
Consult your doctor or pharmacist before using Diclofenaco Teva.
After applying the gel to the skin, a non-occlusive, permeable dressing (bandage) may be applied. Do not use a tight, occlusive dressing.
Children and adolescents
The safety and efficacy of this medication in children have not been established. No data are available.
Other medications and Diclofenaco Teva
Inform your doctor or pharmacist if you are using, have used recently or may need to use any other medication.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
You should not take diclofenaco during the first 6 months of pregnancy unless it is absolutely necessary and your doctor has indicated so. If you need treatment during this period or while trying to become pregnant, use the lowest dose (<30)
You should not use diclofenaco if you are in the last 3 months of pregnancy, as it may harm the fetus or cause complications during delivery.
Breastfeeding
Small amounts of diclofenaco pass into breast milk. Consult your doctor if you are breastfeeding. Diclofenaco Teva may be used during breastfeeding, but do not apply it directly to the breast area or to large skin areas or for an extended period.
Driving and operating machinery
This medication does not affect your ability to drive or operate machinery.
Diclofenaco Teva contains benzyl alcohol
This medication contains 10 mg of benzyl alcohol per gram.
Benzyl alcohol may cause allergic reactions and mild local irritation.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist.If in doubt, consult your doctor or pharmacist again.
The usual treatment period is 60 to 90 days. The maximum effect has been observed in treatments of a duration close to 90 days. It may take up to 1 month from the end of treatment for complete healing.
Wash your hands after applying the gel, except if they are being treated.
Use in children and adolescents
Diclofenaco is not suitable for children or adolescents.
If you use more Diclofenaco Teva than you should
Remove the excess gel by washing the treated skin area with water.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to use Diclofenaco Teva
Continue application following the instructions, but do not apply a double dose of gel to compensate for the missed application.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
If you experience any of the following side effects, stop applying Diclofenaco Teva and inform your doctor as soon as possible:
Skin rash (urticaria); difficulty breathing (sibilant breathing); facial swelling, nasal discharge (allergic rhinitis). These symptoms indicate that you may be allergic to topical diclofenac.
If you consider any of the following side effects you are experiencing to be severe or persistent for a few days, stop using this medication and inform your doctor: itching, skin reaction, skin redness, inflammation, contact dermatitis, pain, and blisters.
Other frequent side effects:(may affect up to 1 in 10 people)
Irritation or tingling in the treated area, conjunctivitis, allergy, painful sensation when touching the skin, pinpricks, muscle stiffness, dermatitis, eczema, dry skin, swelling, generalized redness (covered in scales or blisters), skin thickening, and skin ulcer.
Rare side effects:(may affect up to 1 in 100 people)
Eye pain, excessive tearing/dry eyes, abdominal pain, diarrhea, nausea, hair loss, facial edema, excessive bleeding, greasy skin or skin rash similar to measles.
Side effects that are rare:(may affect up to 1 in 1,000 people)
Large blistering dermatitis.
Very rare side effects:(may affect up to 1 in 10,000 people) Stomach bleeding, kidney problems, difficulty breathing (asthma), skin rash with infection, skin sensitivity to sunlight.
Temporary hair discoloration in the application area has been described. This effect is usually reversible upon discontinuing treatment.
Unknown frequency (cannot be estimated from available data):Burning sensation at the application site
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the tube or the case, after CAD or EXP. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C.
Keep the tube hermetically closed to protect it from light.
Once opened, use within: 6 months.
Medicines should not be disposed of through drains or in the trash. Deposit containers and unused medicines at the SIGRE point of the pharmacy.Ask your pharmacist how to dispose of containers and unused medicines. This will help protect the environment.
Composition of Diclofenaco Teva
Appearance of Diclofenaco Teva and contents of the packaging
Clear, transparent, colorless or pale yellow gel packaged in tubes with a content of 25 grams, 50 grams, 60 grams, 90 grams or 100 grams of gel. Not all packaging sizes may be marketed.
Holder of the marketing authorization
Teva B.V.
Swensweg 5, Haarlem, 2031GA,
Netherlands.
Local Representative:
Teva Pharma S.L.U.
C/ Anabel Segura, 11 - Edificio Albatros B, 1st floor.
28108 – Alcobendas. Madrid (Spain)
Responsible for manufacturing
Balkanpharma Troyan AD, 1 Krayrechna Str., Troyan 5600, Bulgaria
This medicine is authorized in the member states of the European Economic Area with the following names:
DE: Diclofenac AbZ 30mg/g Gel
ES: Diclofenaco Teva 30 mg/g gel
Revision date of this leaflet:December 2023
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
You can access detailed information about this medicine by scanning the QR code included in the packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/83054/P_83054.html
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.